5 questions for Janssen India's boss on TB research and Sirturo
This article was originally published in Scrip
Executive Summary
Janssen's Sirturo (bedaquiline), the first new drug for multidrug-resistant tuberculosis (MDR-TB) with a novel mechanism of action in more than 40 years, is seen as a poster child in the war against the disease.